3Mendelson WB,Roth T,Cassella J,et al. The Treatment of Chronic Insomnia: Drug Indications, Chronic Use and AbuseLiability [ J ]. Summary of a 2001 New Clinical Durg Evaluation Unit Meeting Symposium Sleep Medicine (Reviews) ,2004,8:7
4Holbrookam, Crowther R, Lotter A, et al. The diagnosis and management of insomnia in clinical practice: a p tactical evidence2based app roach[J]. CMAJ,2000,162(2) :216
5Lader MH. Managing dependence and withdrawal with newer hypnotic medications in the treatment of insomnia[J]. Primary Care Companion J Clin Psychiatry,2004,4 ( Suppl1 ):33
6Lader MH. Managing dependence and withdrawal with newer hypnotic medications in the treatment of insomnia[ J]. Primary Care Companion J Clin Psychiatry,2004,4(Suppl 1 ) :33
7Hajak G, Redenbeek A, Vederholzer U, et al. Doxep in in the treatment of primary insomnia: a placebo - controlled, double - blind. polysomnographie study[ J]. J Clin Psychiatry,2001,62(6) :453
8Saletu - zyhlarz GM, Anderer P, Arnold O, et al. Confirmation of the neuro - physiologically predicted therapeutic effects of trazodoneon its target symptoms depression, anxiety and insomnia by postmarkoting clinical studies with acontroUed - release formulation in depressed outpatients [ J ]. Neurop - sychobiology,2003,48 (4) : 194
9Saletu - zyhlarz GM, Abu2bakr MH, Anderer P. Insomnia in dep ression : differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone[ J]. Prog Neurepsy- chopharmacol Biol Psychiatry,2002,26 (2) : 249
10Walsh JK, Schweitzer PK. Ten - year trends in the pharmacological treatment of insomnia[J]. Sleep, 1999,22 (3):371
